Zero Deaths and Hospitalizations: Why Johnson & Johnson’s Coronavirus Vaccine Results Are Much Better Than They Look | Univision Health News

Once Johnson & Johnson announced the Phase III results of its highly anticipated clinical trial of its vaccine, the headlines centered on a fact that has discouraged the public about the potential of this vaccine: 66% effective in preventing the development of moderate symptoms of covid-19, which is overshadowed by about 95% of that of Pfizer or Moderna. But there is an even more important fact that scientists are excited about: 100% effective in preventing death and hospital admissions.

“The headlines are focused on the 66% overall effectiveness, but what’s really important is that the single dose vaccine was 100% effective in preventing serious illness. after 49 days and 85% effective after 28 days. That’s the equivalent of what two doses achieve with RNA vaccines. Our goal is to stop hospitalizations and deaths and all of these vaccines seem to work, ”tweeted physician and researcher Atul Gawande.

For those who don’t “settle” for a lower percentage of protection in the prevention of symptomatic diseases than those achieved with the Pfizer or Moderna vaccines, María Elena Bottazzi, Honduran microbiologist, co-director of the Center for Vaccine Development at Baylor University in Houston reminds them that COVID-19 is a disease that kills more than 1,100 Americans a day, and that about 10-15% of cases develop into serious and even critical illness, requiring hospitalization.

“Right now, it is important to get vaccinated to reduce the risk of serious or critical illness or death. people must agree to be vaccinated without delay with any recognized and available vaccine. While effectiveness varies between vaccines, we know that any protection is better than being completely unprotected. For example, the JJ vaccine protects 85% against serious and critical diseases, which is very similar to the protection provided by Pfizer and Moderna, ”he stressed to Univision Noticias.

So before throwing this vaccine out without knowing in depth the implications of the results, which will be reviewed by the FDA in the coming days, Read below.